CN106491690A - A kind of middle medicine for treating cyclomastopathy - Google Patents
A kind of middle medicine for treating cyclomastopathy Download PDFInfo
- Publication number
- CN106491690A CN106491690A CN201611172642.5A CN201611172642A CN106491690A CN 106491690 A CN106491690 A CN 106491690A CN 201611172642 A CN201611172642 A CN 201611172642A CN 106491690 A CN106491690 A CN 106491690A
- Authority
- CN
- China
- Prior art keywords
- medicine
- cyclomastopathy
- treating
- blood
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of middle medicine for treating cyclomastopathy, belongs to technical field of Chinese medicine.It is made up of following raw materials according medical material：60～65g of roasted SQUAMA MANITIS into puffy with sand, 25～35g of Herba Taraxaci, 25～35g of Cordyceps militaris (L.) Link., 10～15g of Olibanum, 8～12g of Myrrha.The medicine is powder, and every bag of 2g carries out subpackage.Inventive formulation is scientific and reasonable, have soothing liver and strengthening spleen, tonifying both YIN and YANG, adjust equilibrium between yin and yang, heat-clearing and toxic substances removing, dredge the meridian passage, dispersing swelling and dissipating binds, dissipate blood blood stasis removing, regulating qi and activating blood, analgesic therapy chase after poison, strengthening the body resistance the effect of, patient can be allowed from the hardship that operates on, the many deficiency of Western medicine hormoness medication is avoided that again, its treating both the principal and secondary aspects of a disease, there is to cyclomastopathy significant curative effect, and medicine valency is low, short treating period, instant effect, without any side effects, be difficult to recur.Additionally, medicine of the present invention also has certain curative effect to enclosed mass, tumor, tuberculosis.
Description
Technical field
The present invention relates to a kind of middle medicine for treating cyclomastopathy, belongs to technical field of Chinese medicine.
Background technology
Cyclomastopathy is the common mastopathy of women.Also known as cyclomastopathy, mammary dysplasia, Fibrocystic disease
Deng.Cyclomastopathy is named as benign breast dysplasia by World Health Organization (WHO), caused by being a kind of and endocrine dysfunction
Disease.
Clinical symptoms mainly have：1st, mastalgia：It is often distending pain or twinge, one or both sides breast can be involved, with side
Weighting is common, and pain severe patient can not be touched, or even affects daily life and work, pain also may be used based at lump in breast
To Ipsilateral axillary fossa, chest side of body or shoulder back radiation;Some then show as sore nipples or itch, and mastalgia Chang Yuyue premenstrual a couple of days goes out
Show or increase, pain substantially mitigates or disappears after passing through；Pain also can fluctuate with emotion changes, this with menstrual cycle and feelings
Thread changes the main feature that relevant pain is cyclomastopathy clinical manifestation.2nd, lump in breast：Lump can be sent out in unilateral or double
In the breast of side, single or multiple, breast outside upper quadrant is apt to occur in, other quadrants are also found in, lump shape has piece block, tuberosity
Shape, streak, graininess etc., wherein with piece bulk as common, lump border is not obvious, and quality is medium or slightly firmly tough, and activity is good,
With surrounding tissue without adhesion, often there are tenderness, Tumor size to differ, little person is big such as foxtail millet grain, and big person can exceed 3～4cm, lump in breast
Also the characteristics of having with menstrual cycle and change, the moon, premenstrual lump increase was hardened, and after menstrual onset, mass reduction softens.3rd, nipple overflows
Liquid：Small number of patients may occur in which nipple discharge, be spontaneous discharge, olive drab(O．D) or brown slurry discharge.4th, menoxenia：This sufferer
Person simultaneous can see before and after menstruation that irregularly amount is less or color is light, can be with dysmenorrhea.5th, feelings will changes：The normal emotion will of patient is not smooth or vexed
Irritability, on anger, psychentonia or tired postemphasis.
Mainly using two kinds of therapeutic modalities of medicine and operation, Drug therapy is mainly adopted and is swashed western medical treatment cyclomastopathy at present
Extract for treating, but the hormone therapy cycle is long, and DeGrain, cure rate are low, high recurrence rate, large side effects, and medicine valency is expensive, and meeting
The balance of hormone in vivo is further upset.Operative treatment, though good effect, can over the course for the treatment of, not only brings pain to patient
Bitter and postoperative cicatrix, can directly influence the profile of breast and attractive in appearance, and due to sick popularity, recurrent, the handss
The limitation of art, operation are difficult to the purpose for reaching thorough treatment.
The traditional Chinese medical science thinks that cyclomastopathy belongs to " nodules of the breast " category.It is that Chong and Ren channel disorder, liver energy depression and phlegm stagnation are formed by feelings will internal injury.
Content of the invention
In order to overcome defect present in prior art, it is an object of the invention to provide a kind of have heat-clearing and toxic substances removing, lead to
Channels and activating collaterals, dispersing swelling and dissipating binds, dissipate that blood blood stasis removing, regulating qi and activating blood, analgesic therapy are chased after poison, tonifying both YIN and YANG, to adjust equilibrium between yin and yang, strengthening the body resistance effective
The middle medicine for the treatment of cyclomastopathy, can allow patient from the hardship that operates on, be avoided that many deficiencies of Western medicine hormoness medication again,
Its treating both the principal and secondary aspects of a disease, there is to cyclomastopathy significant curative effect, and medicine valency is low, short treating period, instant effect, without any poison secondary, be difficult multiple
Send out.
To achieve these goals, the present invention is employed the following technical solutions：A kind of middle medicine for treating cyclomastopathy, by under
Row raw medicinal material is made：60～65g of roasted SQUAMA MANITIS into puffy with sand, 25～35g of Herba Taraxaci, 25～35g of Cordyceps militaris (L.) Link., 10～15g of Olibanum, Myrrha 8～
12g.
In above-mentioned technical proposal, preferably roasted SQUAMA MANITIS into puffy with sand 63g, Herba Taraxaci 30g, Cordyceps militaris (L.) Link. 30g, Olibanum 12g, Myrrha 10g.
In order to improve drug effect and conveniently take, it is preferable that the medicine is powder, and every bag of 2g carries out subpackage.
Usage and dosage is：2g, a day three times, half an hour warm water delivery service after meal 20 days is a course for the treatment of, general 2
The course for the treatment of can be cured, and serious symptom can be added consolidates a course for the treatment of.
In above-mentioned technical proposal：
Roasted SQUAMA MANITIS into puffy with sand, the Squama Maniss after big gun is processed are heaved in golden yellow, claim roasted SQUAMA MANITIS into puffy with sand.Nature and flavor are salty, cool, are slightly cold.Return liver, stomach.Have
Stimulate the menstrual flow stimulating milk secretion, detumescence and apocenosis, the effects such as search wind and removing obstruction in channels.For amenorrhea abdominal mass, galactostasiss, carbuncle sore tumefacting virus, arthralgia are numb
Contracture.
Herba Taraxaci, nature and flavor are sweet, slight bitter, tremble with fear.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.Cure mainly upper respiratory tract infection, eye conjunctivitis,
Mumps, hyperglycemia, acute mastitis swell and ache, gastritis, dysentery, hepatitis, cholecystitis, acute appendicitiss, urinary system infection, pelvic cavity
Inflammation, carbuncle furuncle furunculosis, pharyngitis control acute mastitiss, and lymphadenitises, scrofula, malignant boil carbuncle toxin, acute conjunctivitiss, cold, fever are acute
Tonsillitiss, acute bronchitiss, urinary tract infection.
Cordyceps militaris (L.) Link., property sweet taste does not warm also not cold and cool, enters lung kidney two warp, and both tonifying the lung is cloudy, and kidney-replenishing, is unique energy
The Chinese crude drug of " tonifying both YIN and YANG, regulation equilibrium between yin and yang ".This is the incomparable unique distinction of other traditional tonic, with weight
The medical value that wants, is excellent health care's tonic, Traditional Chinese Medicine be usually used in chronic cough dyspnea due to deficiency, chronic cough hemoptysis, impotence and seminal emission,
The treatment of many deficient syndromes of soreness of waist and knee joint etc..Cordyceps militaris (L.) Link. contains cordycepin, cordycepic acid, adenosine, Cordyceps polysaccharide, ergosterol, super
Superoxide dismutase（SOD）, selenium（Se）Isoreactivity composition；Wherein, cordycepin has antiviral, antibacterial, substantially suppresses tumor life
The effects such as synthesis of long, interference human body RNA and DNA；Cordycepic acid has prophylactic treatment cerebral thrombosiss, cerebral hemorrhage, renal failure, profit
The effects such as urine；Adenosine has antiviral, antibacterial, and prophylactic treatment cerebral thrombosiss, cerebral hemorrhage suppress Platelet congregation, anti-tampon shape
Into the effects such as；The effects such as Cordyceps polysaccharide has enhance immunity, slow down aging, strengthening the body resistance, cardioprotection, liver, spasmolytic；Wheat
The effects such as angle sterol has anticancer, anti-ageing, attenuation；Superoxide dismutase (SOD) has to suppress or eliminate urges the super of people's aging
The effects such as oxygen-derived free radicals formation and anticancer, anti-ageing, attenuation；Selenium (Se) has the effects such as strengthening human body immunity.
Olibanum, nature and flavor are worked hard, temperature.GUIXIN, liver, spleen channel.There is regulating qi and activating blood, analgesic therapy, the effect of chasing after poison.Control QI and blood to coagulate
Stagnant, trusted subordinate's pain, ulcerative carbuncle pyogenic infections, traumatic injury, dysmenorrhea, postnatal blood stasis twinge.《Do not record》：Treat edema due to wind pathogen poison swollen, remove bad odor.Treat wind
Urticaria poison of itching.《Bencao Shiyi》：Deaf, apoplexy locked mouth is treated, married woman's vim and vigour can send out wine, and reason is air-cooled, and only large intestine is let out, and treats all skin ulcers
Make internal diabetes.《Pearl sac》：Fixed all through pain.《Detailed outline》：The all poison of eliminating carbuncle cellulitis, Tuoli shield heart, analgesic therapy of invigorating blood circulation are stretched muscle, control married woman difficult
Produce, injured.
Myrrha, nature and flavor are bitter, pungent, put down.Enter liver, spleen, the heart, kidney channel.There is promoting blood circulation and stopping pain, dissipate the work(such as blood blood stasis removing, detumescence and promoting granulation
Effect.Cure mainly chest and abdomen stasis caused pain, dysmenorrhea, amenorrhea, traumatic injury, carbuncle swells sore, acute appendicitis, conjunctival congestion and swelling pain.Match somebody with somebody Olibanum, promoting blood circulation to remove blood stasis, OK
Gas relaxing muscles and tendons；Match somebody with somebody Squama Maniss, invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain.
Compared with the prior art, the present invention with Chinese medicine and pharmacy theory as foundation, on the basis of Empirical formula among the people prepare and
Into.Its scientific formulation rationally, with soothing liver and strengthening spleen, tonifying both YIN and YANG, adjusts equilibrium between yin and yang, heat-clearing and toxic substances removing, dredge the meridian passage, Sweeling-eliminating medicine powder
Knot, dissipate blood blood stasis removing, regulating qi and activating blood, analgesic therapy chase after poison, strengthening the body resistance the effect of, patient can be allowed from the hardship that operates on, be avoided that again
Many deficiencies of Western medicine hormoness medication, its treating both the principal and secondary aspects of a disease, have significant curative effect to cyclomastopathy, and medicine valency is low, short treating period,
Instant effect, without any side effects, be difficult to recur.Additionally, medicine of the present invention also has necessarily to enclosed mass, tumor, tuberculosis
Curative effect.
Specific embodiment
With reference to specific embodiment, the present invention is further illustrated：
Embodiment 1：A kind of middle medicine for treating cyclomastopathy, is made up of following raw materials according medical material：Roasted SQUAMA MANITIS into puffy with sand 60g, Herba Taraxaci 35g,
Cordyceps militaris (L.) Link. 25g, Olibanum 15g, Myrrha 8g.The medicine is powder, and its manufacture method is that each medicine is polished into powder respectively, uniformly stirs
Mix, every bag of 2g carries out subpackage.
Embodiment 2：A kind of middle medicine for treating cyclomastopathy, is made up of following raw materials according medical material：Roasted SQUAMA MANITIS into puffy with sand 63g, Herba Taraxaci
30g, Cordyceps militaris (L.) Link. 30g, Olibanum 12g, Myrrha 10g.The medicine is powder, and its manufacture method is that each medicine is polished into powder respectively,
Uniform stirring, every bag of 2g carry out subpackage.
Embodiment 3：A kind of middle medicine for treating cyclomastopathy, is made up of following raw materials according medical material：Roasted SQUAMA MANITIS into puffy with sand 65g, Herba Taraxaci
25g, Cordyceps militaris (L.) Link. 35g, Olibanum 10g, Myrrha 12g.The medicine is powder, and its manufacture method is that each medicine is polished into powder respectively,
Uniform stirring, every bag of 2g carry out subpackage.
Clinical data is as follows：
The present inventor accepts patient group patient 560 for medical treatment, is women, and the age is minimum 18 years old, and the oldest 73 years old, the course of disease was most
Short 2 months, most long 28 years.18 years old～30 years old 88：Slight hypertrophy 45, moderate hypertrophy 38, severe hypertrophy 5；31
Year～50 years old 402：Slight hypertrophy 180, moderate hypertrophy 190, severe hypertrophy 32；More than 51 years old 70：Slight increasing
Raw 30, moderate hypertrophy 30, severe hypertrophy 10.Clinical manifestation：Slight hypertrophy, feels distending pain, before menstrual onset substantially,
After menstrual onset, distending pain sense is gone down or is disappeared.Palpation：Mammary gland is thickened in piece film sample, and matter is tough, locally has slight tenderness.Color ultrasound：Double
Side corpus mamma is arranged owes rule, and lobule echo owes, not visiting and obvious abnormity agglomerate.Moderate hypertrophy, feels distending pain, menstruation
The last week substantially, gradually increases, goes down or disappear after menstruation.Palpation：Mammary gland is thickened in piece film sample, matter is tough hard, and tenderness is obvious.Color
Super：Bilateral breast body of gland irregular arrangement, lobule Echo heterogenicity, conduit move towards disorderly, and with tuberosity, border is clear.Severe hypertrophy：
Obvious distending pain, affects sleep, the moon premenstrual pain, be unable to spontaneous remission after menstruation.Palpation：Hurt like hell, mammary gland are thickened such as lump, matter
Firmly tough.Color ultrasound：Bilateral breast body of gland irregular arrangement, lobule Echo heterogenicity, conduit move towards disorderly, see multiple low in double mammary gland bodies
Echo area.Therapeutic Method：According to main suit, after making a definite diagnosis through palpation, color ultrasound examination, give medicine of the present invention and treated, a 2g,
A day three times, half an hour warm water delivery service after meal, 20 days is a course for the treatment of.
Therapeutic evaluation：Cure, 1, the autonomous symptom of patient disappears.2nd, palpation：Mammary gland is soft, without tenderness.3rd, color ultrasound：Body of gland
Echo is normal.Take a turn for the better, 1, the autonomous symptom of patient disappears.2nd, palpation：Mammary gland is soft, and still there is tenderness local.3rd, color ultrasound：Lobule echo
Owe.Invalid：Through 3 course of therapy symptoms without improvement.
Therapeutic effect：1st, 18 years old～30 years old：Slight hypertrophy is all cured through a course for the treatment of；Moderate hypertrophy is treated through 1～2
Journey is all cured；Severe hypertrophy is all cured through 1～3 course for the treatment of.2nd, 31 years old～50 years old：Slight hypertrophy is whole through a course for the treatment of
Cure；Moderate hypertrophy is all cured through 1～2 course for the treatment of；Severe hypertrophy is cured through 1～3 course for the treatment of 28,4 take a turn for the better, 0
Example is invalid.3rd, more than 51 years old：Slight hypertrophy is all cured through a course for the treatment of；Moderate hypertrophy is all cured through 2 courses for the treatment of；Severe increases
Raw cure through 3 courses for the treatment of 5,3 take a turn for the better, 2 invalid.Clinical cure rate：98%, effective percentage：99.6%, inefficiency：
0.4%.
Model case is as follows：
Tian Li, 32 years old, company clerk.Readme：Double mammary swelling pains 3 years, menstruation the last week, gradually increase, have delayed after menstruation
Solution.Look into：Double newborn outside upper quadrants are in that piece is membranaceous to be thickened, and matter is tough hard, and tenderness sense is heavier.Color ultrasound：Bilateral breast body of gland irregular arrangement,
Lobule Echo heterogenicity, conduit move towards disorderly, and with tuberosity, border is clear.Carry out treating 2 courses for the treatment of healings using medicine of the present invention.
Follow-up after 1 year, without recurrence.
Xiang Fangfang, 18 years old, students.Readme：Double mammary swelling pains 6 months, subtract after menstrual onset before menstrual onset substantially
Gently.Look into：Double newborn outside upper quadrants are thickened in piece film sample, and matter is tough, mild tenderness.Color ultrasound：Rule, lobule are owed in the arrangement of bilateral breast body of gland
Echo owes, not touching obvious abnormity agglomerate.Carry out treating 1 course for the treatment of healing using medicine of the present invention.Follow-up after 1 year, nothing
Recurrence.
Liu Jia, 63 years old, retired person.Readme：Double mammary swelling pains have difficulty in going to sleep 2 years.Look into：Double breast in upper, outside upper, outer lower as
Limit is thickened in piece film sample, is attached most importance to outside upper quadrant especially, and matter is firmly tough, tenderness sense weight.Color ultrasound：The arrangement of bilateral breast body of gland is not advised
Then, lobule Echo heterogenicity, conduit move towards disorderly, see multiple low echo areas in double mammary gland bodies.Treated using medicine of the present invention
3 courses for the treatment of are cured.Follow-up after 1 year, without recurrence.
Claims (3)
1. a kind of middle medicine for treating cyclomastopathy, it is characterised in that be made up of following raw materials according medical material：60～65g of roasted SQUAMA MANITIS into puffy with sand, Pu
25～35g of Herba Taraxaci, 25～35g of Cordyceps militaris (L.) Link., 10～15g of Olibanum, 8～12g of Myrrha.
2. a kind of middle medicine for treating cyclomastopathy, it is characterised in that be made up of following raw materials according medical material：Roasted SQUAMA MANITIS into puffy with sand 63g, Herba Taraxaci
30g, Cordyceps militaris (L.) Link. 30g, Olibanum 12g, Myrrha 10g.
3. as claimed in claim 1 or 2 treatment cyclomastopathy middle medicine, it is characterised in that：The medicine be powder, every bag of 2g
Carry out subpackage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611172642.5A CN106491690A (en) | 2016-12-18 | 2016-12-18 | A kind of middle medicine for treating cyclomastopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611172642.5A CN106491690A (en) | 2016-12-18 | 2016-12-18 | A kind of middle medicine for treating cyclomastopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106491690A true CN106491690A (en) | 2017-03-15 |
Family
ID=58333271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611172642.5A Pending CN106491690A (en) | 2016-12-18 | 2016-12-18 | A kind of middle medicine for treating cyclomastopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106491690A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113082137A (en) * | 2021-04-23 | 2021-07-09 | 王蕾 | External plaster for treating breast diseases and preparation method thereof |
-
2016
- 2016-12-18 CN CN201611172642.5A patent/CN106491690A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113082137A (en) * | 2021-04-23 | 2021-07-09 | 王蕾 | External plaster for treating breast diseases and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101524464B (en) | Pure traditional Chinese medicine composition for treating female breast diseases and pure traditional Chinese medicine preparation prepared thereby | |
| CN100556446C (en) | The Chinese medicine of treatment hepatocarcinoma | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN102145101A (en) | Novel traditional Chinese medicine for treating rheumatic lumbocrural pains | |
| CN103405682A (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
| CN102824445A (en) | Traditional Chinese medicine composition for treating duodenal ulcer | |
| CN106491690A (en) | A kind of middle medicine for treating cyclomastopathy | |
| CN105106753A (en) | Mealworm health-care product improving immunity | |
| CN104107393A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN102895392B (en) | Chinese medicine for treating duodenal ulcer | |
| CN104689239A (en) | Traditional Chinese medicine composition for treating cholelithiasis and preparation method thereof | |
| CN103340975A (en) | Traditional Chinese medicine for treating duodenal ulcer | |
| CN104543986A (en) | Formula of hericium erinaceus soup capable of activating blood circulation and nourishing heart and production method of hericium erinaceus soup | |
| CN104784616A (en) | Traditional Chinese medicine composition for treating syndrome of yang deficiency of spleen and kidney | |
| CN104491060A (en) | Tradtional Chinese medicine for preventing relapse of glioma | |
| CN103784689A (en) | Medicinal composition for treating leukemia | |
| CN104173659B (en) | Chinese medicine composition of the few breast for the treatment of postpartum caused by hepatic stagnation qi stagnation and preparation method thereof | |
| CN102988902B (en) | Traditional Chinese medicine pill for treating fatty liver | |
| CN102688443B (en) | Traditional Chinese medicine for foundationally treating gastritis and colitis, and preparation method thereof | |
| CN106492124A (en) | A kind of Chinese medicine composition and preparation method thereof and the application for the treatment of cervical cancer | |
| CN105833228A (en) | Drug preparation for reversing gastric cancer drug resistance and application thereof | |
| CN104606391A (en) | Traditional Chinese medicine composition for treating duodenal ulcers | |
| CN105395733A (en) | Traditional Chinese medicine composition used for treating chronic gastritis and preparation method therefor | |
| CN104784587A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia type infertility and preparation method thereof | |
| CN104740013A (en) | Traditional Chinese medicine composition for treating malignant tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170315 |